Compliance with Pregnancy Prevention Recommendations for Isotretinoin Following the Amendment of the European Union Pregnancy Prevention Program: A Repeat Study in Estonia
Abstract Background Isotretinoin, indicated for severe acne, is a potent teratogen and therefore contraindicated in pregnancy. Thus, the pregnancy prevention program (PPP) for isotretinoin has been introduced. Objectives The aim of this study was to assess the concomitant use of isotretinoin and eff...
Saved in:
Main Authors: | Maaja Ivask (Author), Katrin Kurvits (Author), Maia Uusküla (Author), Anne Juppo (Author), Ott Laius (Author), Mia Siven (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends in opioid prescribing in Estonia (2011‐2017)
by: Anneli Uusküla, et al.
Published: (2020) -
The COVID-19 pandemic and the use of benzodiazepines and benzodiazepine-related drugs in Estonia: an interrupted time-series analysis
by: Katrin Kurvits, et al.
Published: (2024) -
Non-compliance with pregnancy prevention recommendations for isotretinoin in Korea between 2019-2020
by: Eun Jeong Choi, et al.
Published: (2021) -
IMPACT OF JUDO RULES AMENDMENTS OVER TRAUMA PREVENTION
by: CHIRAZI Marin
Published: (2020) -
Isotretinoin; A review on the Utilization Pattern in Pregnancy
by: Sajad Khiali, et al.
Published: (2018)